Digital Health Technologies

Digital Health Technologies (DHTs) refer to digital tools and devices used for health-related purposes, including AI-driven diagnostics and remote monitoring. According to WHO's risk-adjusted guidance and ISO 42001, DHTs must be evaluated for both technical reliability and ethical considerations. Unlike traditional medical devices, DHTs rely heavily on continuous data-driven updates, making risk-adjusted-governance essential. In the context of the EU AI Act and GDPR Article 22, companies must ensure AI-driven health decisions are explainable and subject to human oversight. This is particularly critical for mental health applications where autonomy and ethics are paramount. Taiwan's Personal Data Protection Act (Article 27) also mandates strict handling of sensitive health data, which must be integrated into the DHT development lifecycle.

Implementation follows a three-step framework: Risk Classification, Control Design, and Continuous Monitoring. First, categorize DHTs by risk level—AI diagnostic tools are typically high-risk under the EU AI Act. Second, implement controls based on ISO 42001, including data--quality assurance and bias mitigation. Third, establish post-market surveillance to monitor model drift. For example, a Taiwan-based AI startup implementing these standards saw a 25% reduction in regulatory delays when applying for CE marking. Key performance indicators (KPIs) include: AI bias-adjusted accuracy (target >95%), data-related compliance incidents (target <1 per year), and model-drift detection response time (target <24 hours).

Three primary challenges exist: Regulatory ambiguity, data-siloing, and talent shortages. The EU AI Act's risk-based approach and the EU AI Act's implementation timeline (2024-2026) create pressure for Taiwan exporters to be closely monitored. Data-siloing can be addressed by adopting ISO 27701 standards for privacy information management. Talent shortages require a combination of upskilling existing staff and partnering with specialized consultants. The recommended priority is: Month 1: Risk-adjusted inventory; Month 2: ISO 42001 framework establishment; Month 3: Pilot implementation and internal audit. This structured approach ensures compliance before scaling to international markets.

Winners Consulting Services Co., Ltd. specializes in Digital Health Technologies for Taiwan enterprises, delivering compliant management systems within 90 days. We provide end-to-end guidance—from ISO 42001 implementation to EU AI Act readiness—ensuring your AI products meet global standards. Free consultation: https://winners.com.tw/contact